Today, stigma remains as alive and well as ever while the epidemic evolves, except that now it’s a pill for HIV prevention that has moralistic panties up in a bunch.
In the first lawsuit of its kind in the United States, last week GLAD filed a claim with the Massachusetts Commission Against Discrimination (MCAD), charging Mutual of Omaha Insurance Company with discrimination for denying a gay man long-term care insurance because he is taking Truvada as PrEP.
The Body: Truvada Approved to Reduce the Risk of Sexually Transmitted HIV in People Who Are Not Infected With the Virus
The Food and Drug Administration approved Truvada (a fixed dose combination of emtricitabine/tenofovir disoproxil fumarate) to reduce the risk of HIV infection in uninfected individuals.
TheBody.com spoke to Stone on Jan. 16 to talk about why and how this bill came about. He said, “Someone suggested it to us, and we thought it was a good idea.”
The number of adults age 50-plus living with HIV/AIDS has been growing in recent years, with the group accounting for 24 percent of people with the infection in 2005, up from 17 percent in 2001, according to CDC.
In what has been described as a “major breakthrough,” the daily use of an antiretroviral drug by HIV-negative gay and bisexual men has been proved to dramatically reduce new HIV infections.